Table 1 Coupling-amination-aza-annulation-Pictet–Spengler (CAAPS) sequence to indolo[2,3-a]quinolizin-4-ones 7
a,b-Unsaturated acid
Entry Acid chloride 1
Alkyne 2
Tryptamine 6 chloride 4
Tetrahydro-b-carboline 7 (yield)
1a
2a
3a
4a
5a
R1 = 2-thienyl (1a)
R2 nBu (2a) R3 = H (6a)
6a
6a
R2 = Ph (2b) 6a
=
R4 = R5 = H (4a) 7a (R1 = 2-thienyl, R2
=
7b (R1 = p-O2NC6H4, R2
7c (R1 = p-MeOC6H4, R2
nBu , R3 = R4 = R5 = H, 52%)
=
=
R1 = p-O2NC6H4 (1b) 2a
4a
4a
4a
nBu , R3 = R4 = R5 = H, 43%)
nBu, R3 = R4 = R5 = H, 59%)
R1 = p-MeOC6H4 (1c) 2a
1a
1a
7d (R1 = 2-thienyl, R2 = Ph, R3 = R4 = R5 = H, 41%)
2a
6a
R4 = H, R5 = CH3 7e (R1 = 2-thienyl, R2
(4b)
=
nBu, R3 = R4 = H, R5 = CH3, 50%)
6a
1a
2a
6a
R4 = CH3, R5 = H 7f (R1 = 2-thienyl, R2
(4c)
4a
=
nBu, R3 = R5 = H, R4 = CH3, 54%,
syn–syn/syn–anti = 4.5 : 1)b
7a
8d
1a
1a
R2 = TMS (2c) 6ac
2a
7g (R1 = 2-thienyl, R2 = R3 = R4 = R5 = H, 32%)
R3 = CO2CH3 4a
7h (R1 = 2-thienyl, R2 nBu, R3 = CO2Me, R4 = R5 = H,
=
(6b)e
45%)
a In THF. b The mixture of diastereomers was separated by column chromatography. c After the coupling step 1.00 mmol of an aqueous TBAF solution was
added prior to the addition of 6a. d In toluene. e Additionally, together with 2.00 mmol of 6b (as a hydrochloride), 0.28 mL (2.00 mmol) of triethylamine were
added.
5 For a recent review, see e.g.: K. Sonogashira, J. Organomet. Chem.,
2002, 653, 46.
6 A. S. Karpov and T. J. J. Müller, Org. Lett., 2003, 5, 3451.
7 A. S. Karpov and T. J. J. Müller, Synthesis, 2003, 2815.
8 For recent reviews on the synthetic potential of enaminones in
heterocycle syntheses, see e.g.: Y. V. Smirnova and Z. A. Krasnaya,
Russ. Chem. Rev., 2000, 69, 1021; J. P. Michael, C. B. De Koning, D.
Gravestock, G. D. Hosken, A. S. Howard, C. M. Jungmann, R. W. M.
Krause, A. S. Parsons, S. C. Pelly and T. V. Stanbury, Pure Appl. Chem.,
1999, 71, 979; P. Lue and J. V. Greenhill, Adv. Heterocycl. Chem., 1997,
67, 207.
9 For recent examples of aza-annulations, see e.g.: K. Paulvannan and T.
Chen, J. Org. Chem., 2000, 65, 6160; P. Benovsky, G. A. Stephenson
and J. R. Stille, J. Am. Chem. Soc., 1998, 120, 2493.
10 For a recent review, see e.g.: E. D. Cox and J. M. Cook, Chem. Rev.,
1995, 95, 1797.
11 Typical procedure (Compound 7c): in a screw cap pressure vessel 14 mg
(0.02 mmol) of Pd(PPh3)2Cl2, and 7 mg (0.04 mmol) of CuI were
Fig. 1 Molecular structure of 7h (R1 = 2-thienyl, R2 = nBu, R3
CO2CH3, R4 R5
H). For a better overview only one of both
independent host molecules is shown.
=
dissolved in 5 mL of degassed THF or toluene. Then 0.14 mL (1.00
mmol) of triethylamine, as well as 171 mg (1.00 mmol) of 1c and 0.12
mL (1.05 mmol) of 2a were successively added to the solution. The
reaction mixture was stirred at room temperature for 1 h. Then, 320 mg
(2.00 mmol) of tryptamine (6a) were added and the reaction mixture
was heated to 70 °C and maintained at this temperature over 10 h. Then,
0.41 mL (5.00 mmol) of acryloyl chloride (4a) was added and the
reaction mixture was heated to 70 °C and maintained at this temperature
over 3 h. The reaction mixture was diluted with methanol and stirred for
10 min. Then, after workup and chromatography (silica gel, diethyl
ether) 254 mg (59%) of the analytically pure tetrahydro-b-carboline 7c
was obtained as colorless crystals, mp. 201–202 °C, [a]D24 +178° (c =
2.0, CH2Cl2). Rf = 0.25 (diethylether). 1H NMR (CDCl3, 300 MHz): d,
0.85 (t, J, = 7.0 Hz, 3 H), 1.05–1.40 (m, 4 H), 1.96–2.12 (m, 1 H),
2.20–2.40 (m, 2 H), 2.75–3.07 (m, 6 H), 3.74 (s, 3 H), 3.93 (dd, J, =
13.2 Hz, J, = 4.9 Hz, 1 H), 5.23–5.31 (m, 1 H), 6.74 (d, J, = 9.0 Hz,
2 H), 7.04–7.17 (m, 3 H), 7.46–7.52 (m, 1 H), 7.66 (d, J, = 9.0 Hz, 2 H),
8.27 (s, 1 H). 13C NMR (CDCl3, 75 MHz): d, 13.9 (CH3), 20.9 (CH2),
21.5 (CH2), 23.2 (CH2), 27.2 (CH2), 29.6 (CH2), 35.7 (CH2), 39.8
(CH2), 52.6 (CH), 55.3 (CH3), 62.0 (Cquat), 110.7 (Cquat), 111.0 (CH),
113.7 (CH), 118.0 (CH), 119.3 (CH), 121.8 (CH), 125.9 (Cquat), 129.4
(Cquat), 130.3 (CH), 134.3 (Cquat), 135.7 (Cquat), 163.7 (Cquat), 169.6
(Cquat), 201.5 (Cquat). Anal. calcd. for C27H30N2O3 (430.6): C 75.32, H
7.02, N 6.51. Found: C 74.93, H 7.01, N 6.46%.
=
=
synthesis and the concomitant enhancement of molecular diversity
in pharmaceutically interesting targets are currently underway.
The authors gratefully acknowledge the financial support by
DFG (Graduiertenkolleg 850), MORPHOCHEM AG, München,
Fonds der Chemischen Industrie, and Dr.-Otto-Röhm Gedächt-
nisstiftung.
Notes and references
‡ Crystal data 7h: C26H28N2O4S·CH2Cl2, M = 549.5, monoclinic, space
group P21, a = 12.022(1), b = 14.950(1), c = 14.663(1) Å, a = 90.0, b
= 94.869(2), g = 90.0°, V = 2625.9(4) Å3, T = 100(2) K, Z = 4, r =
1.390 g cm23, crystal dimensions 0.21 3 0.15 3 0.12 mm3, Mo Ka
radiation, m = 0.364 mm21, l = 0.71073 Å. Data were collected on a
Bruker Smart APEX diffractometer and a total of 10561 of the 23151
reflections were unique [R(int) = 0.0423]. Refinement on F2, wR2 = 0.107
(observed reflections), R1 = 0.050 for [I > 2s(I)]. CCDC 235421. See
.cif or other electronic format.
12 For a recent review on cyclization of N-acyliminium ions, see e.g.: B. E.
Maryanoff, H.-C. Zhang, J. H. Cohen, I. J. Turchi and C. A. Maryanoff,
Chem. Rev., 2004, 104, 1431.
13 The aza-annulation-Pictet–Spengler reaction was reported last year
independently from our group: M. M. Abelman, J. K. Curtis and D. R.
James, Tetrahedron Lett., 2003, 44, 6527.
1 For recent reviews, see e.g.: I. Ugi, A. Dömling and B. Werner, J.
Heterocycl. Chem., 2000, 37, 647; L. Weber, K. Illgen and M.
Almstetter, Synlett, 1999, 366.
2 S. Kobayashi, Chem. Soc. Rev., 1999, 28, 1.
3 See e.g.: A. S. Karpov, F. Rominger and T. J. J. Müller, J. Org. Chem.,
2003, 68, 1503; T. J. J. Müller, J. P. Robert, E. Schmälzlin, C. Bräuchle
and K. Meerholz, Org. Lett., 2000, 2, 2419; T. J. J. Müller, M. Ansorge
and D. Aktah, Angew. Chem., Int. Ed., 2000, 39, 1253.
4 For recent reviews on transition metal assisted sequential transforma-
tions, see e.g.: G. Balme, E. Bossharth and N. Monteiro, Eur. J. Org.
Chem., 2003, 4101; G. Battistuzzi, S. Cacchi and G. Fabrizi, Eur. J. Org.
Chem., 2002, 2671.
14 For overviews, see e.g.: E. Breitmaier, Alkaloide, Teubner Stud-
ienbücher, Stuttgart, 1997, p. 52; K. Stuart and R. Woo-Ming,
Heterocycles, 1975, 3, 223.
15 For reviews, see e.g.: S. Urban, S. J. H. Hickford, J. W. Blunt and M. H.
G. Munro, Curr. Org. Chem., 2000, 4, 765; J. B. Hudson, Antiviral Res.,
1989, 12, 55; D. J. McKenna and G. H. Towers, J. Psychoact. Drugs,
1984, 16, 347.
16 B. T. Ho, J. Pharm. Sci., 1972, 61, 821.
C h e m . C o m m u n . , 2 0 0 4 , 1 5 0 2 – 1 5 0 3
1503